Home›Companies›Biotech & Pharma›2A Biosciences

2A Biosciences, Inc.

Updated Oct 27, 2026·Latest SEC filing Jul 27, 2023·Suggest an edit

About 2A Biosciences

2A Biosciences is a private company based in Santa Monica, California, incorporated in 2022 in Delaware. It has reported $3,779,777 raised in one offering on Form D since March 2023. Its chief executive is Alexander Speiser.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Mar 1, 2023Mar 14, 2023amended Jul 27, 2023$3,779,777of $5.5M target13$290KEquity, Securities on exercise, SAFE (Simple Agreement for Future Equity) securities, including underlying securities upon conversion of SAFEsRule 506(b)Form D/A ↗1 earlier filing

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on 2A Biosciences's Form D filed Jul 27, 2023.

GD
Gopal Das
Director
AS
Alexander Speiser
Chief Executive Officer and director
CN
Charles Nichols
Chief Scientific Officer and director
TF
Timothy Foster
Head of Research and director
DN
David Nichols
Chief Drug Discovery Officer and director

Sources

  1. SEC2A Biosciences, Inc. Form D, filed Mar 14, 2023
  2. SEC2A Biosciences, Inc. filing history